Erlotinib Terminated Phase 1 / 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Supportive Care

IndicationsStatusPurposePhase
TerminatedSupportive Care1 / 2
clinicaltrials.gov IdentifierTitleDrugs